Seizure · 2026
Burden of headache among people with epilepsy: A systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sharma Arkansh, Paruchuri Amith, Kola Pavan Raju, P Nimisha, Pal Ayushi, Agarwal Harshita, Tiwari Hemant Kumar, Nuthalapati Poojith, Beriwal Nitya, Kansal Bhavya, Garg Ravindra Kumar, Malhotra Hardeep Singh, Singh Anuradha, Singh Mamta Bhushan, Suresh Vinay
Аннотация
BACKGROUND: Headache and epilepsy frequently coexist, likely reflecting shared mechanisms such as cortical hyperexcitability and genetic susceptibility. However, the burden of headache in people with epilepsy (PWE), particularly in children, remains uncertain.
METHODS: We performed a systematic review and meta-analysis (PROSPERO: CRD420251000235) of observational studies reporting headache prevalence in PWE. MEDLINE, EMBASE, Scopus, and Web of Science were searched to January 2026. Random-effects meta-analyses of proportions were conducted, with subgroup analyses by geography, age, and headache subtypes. Publication bias was assessed using Doi plots and the LFK index.
RESULTS: Seventy-three studies including 103,357 PWE (2067 children) were analyzed. The pooled prevalence of headache among PWE was estimated at 40.36% (36.51-44.32); in children, it was 27.5% (95% CI: 19.7-36.1). Prevalence varied significantly by geographic region (p < 0.0001), highest in Africa and lowest in North America. Among headaches temporally related to seizures, interictal headache was reported in 35.48% (95% CI: 26.17%-46.04%), and postictal headache in 27.06% (95% CI: 22.53%-32.12%), representing the most frequent subtypes. Patients receiving polytherapy had lower headache prevalence compared with those on monotherapy. Publication bias was evident for several outcomes.
CONCLUSIONS: Headache affects nearly two in five individuals with epilepsy and over one in four children, representing a substantial and underrecognized burden. Routine, standardized headache assessment should be integrated into epilepsy care. Future prospective, pediatric-inclusive studies using contemporary diagnostic criteria are needed to refine prevalence estimates and guide management.
METHODS: We performed a systematic review and meta-analysis (PROSPERO: CRD420251000235) of observational studies reporting headache prevalence in PWE. MEDLINE, EMBASE, Scopus, and Web of Science were searched to January 2026. Random-effects meta-analyses of proportions were conducted, with subgroup analyses by geography, age, and headache subtypes. Publication bias was assessed using Doi plots and the LFK index.
RESULTS: Seventy-three studies including 103,357 PWE (2067 children) were analyzed. The pooled prevalence of headache among PWE was estimated at 40.36% (36.51-44.32); in children, it was 27.5% (95% CI: 19.7-36.1). Prevalence varied significantly by geographic region (p < 0.0001), highest in Africa and lowest in North America. Among headaches temporally related to seizures, interictal headache was reported in 35.48% (95% CI: 26.17%-46.04%), and postictal headache in 27.06% (95% CI: 22.53%-32.12%), representing the most frequent subtypes. Patients receiving polytherapy had lower headache prevalence compared with those on monotherapy. Publication bias was evident for several outcomes.
CONCLUSIONS: Headache affects nearly two in five individuals with epilepsy and over one in four children, representing a substantial and underrecognized burden. Routine, standardized headache assessment should be integrated into epilepsy care. Future prospective, pediatric-inclusive studies using contemporary diagnostic criteria are needed to refine prevalence estimates and guide management.